Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Fouzia Guestini
Katsuhiko Ono
Minoru Miyashita
Takanori Ishida
Noriaki Ohuchi
Saki Nakagawa
Hisashi Hirakawa
Kentaro Tamaki
Yasuyo Ohi
Yoshiaki Rai
Yasuaki Sagara
Hironobu Sasano
Keely May McNamara
机构：
[1] Tohoku University,
[2] Tohoku Kousai Hospital,undefined
[3] Nahanishi Clinic,undefined
[4] Sagara Hospital,undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 173卷
关键词：
Triple-negative breast cancer; Neoadjuvant chemotherapy; Mechanistic markers; Drug resistance; Residual disease; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 288
页数：13
相关论文
共 50 条
  • [31] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [32] Value of SUVmax, Ki-67, EGFR, P53 in Predicting the Effect of neoadjuvant Chemotherapy in Triple-negative Breast Cancer
    Li, Wen
    Feng, Yan-lin
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [33] Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
    Ruo-Xi Wang
    Sheng Chen
    Xi Jin
    Zhi-Ming Shao
    Scientific Reports, 6
  • [34] Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
    Wang, Ruo-Xi
    Chen, Sheng
    Jin, Xi
    Shao, Zhi-Ming
    SCIENTIFIC REPORTS, 2016, 6
  • [35] Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Mo, Qin-Guo
    Wei, Chang-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6862 - 6870
  • [36] Prognostic Impact of Residual Disease After Neoadjuvant Chemotherapy in 648 Patients with Triple-negative Breast Cancer
    Kern, Peter
    Von Minckwitz, Gunter
    Puetter, Carolin
    Pavlidou, Sofia
    Flach, Annika
    Kimmig, Rainer
    Rezai, Mahdi
    ANTICANCER RESEARCH, 2015, 35 (10) : 5479 - 5484
  • [37] Prognostic Factors in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Fujii, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140
  • [38] Correlation between Ki67 and Histological Grade in Breast Cancer Patients Treated with Preoperative Chemotherapy
    Petric, Militza
    Martinez, Santiago
    Acevedo, Francisco
    Oddo, David
    Artigas, Rocio
    Camus, Mauricio
    Sanchez, Cesar
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (23) : 10277 - 10280
  • [39] KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance
    Arafah, Maria A.
    Ouban, Abderrahman
    Ameer, Omar Z.
    Quek, Ko Jin
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2021, 15
  • [40] Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer
    V. Zenzola
    M. A. Cabezas-Quintario
    M. Arguelles
    E. Pérez-Fernández
    Y. Izarzugaza
    A. Correa
    J. García-Foncillas
    Clinical and Translational Oncology, 2018, 20 : 1448 - 1454
12345